Stryker

$242.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.09 (-1.26%) Today
-$0.02 (-0.01%) As of 12:59 AM UTC after-hours

Why Robinhood?

You can buy or sell Stryker and other stocks, options, and ETFs commission-free!

About SYK

Stryker Corp. engages in the provision of medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The MedSurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI. The listed name for SYK is Stryker Corporation.

CEO
Kevin A. Lobo
Employees
43,000
Headquarters
Kalamazoo, Michigan
Founded
1941
Market Cap
91.59B
Price-Earnings Ratio
58.46
Dividend Yield
0.96
Average Volume
1.49M
High Today
$246.79
Low Today
$242.11
Open Price
$246.79
Volume
1.16M
52 Week High
$250.02
52 Week Low
$124.54

SYK News

MarketWatch22h

Stryker Corp. stock falls Friday, underperforms market

Shares of Stryker Corp. SYK, -1.26% slipped 1.26% to $242.69 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&

SYK Earnings

$0.00
$0.94
$1.87
$2.81
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 29, After Hours

You May Also Like

FJUL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure